@kpwhatspoppin's semaglutide claims, fact-checked

What did @kpwhatspoppin actually say?

Honestly? Almost nothing verifiable. The transcript is essentially a repeated phrase: "I tuck the drugs and the drugs are working." That's it. There's no dosage mentioned, no timeline, no side effects disclosed, no medical supervision referenced. The caption does more heavy lifting than the video itself, framing this as a personal "semaglutide journey" that "truly worked" for unspecified "weight loss issues."

What the creator actually delivers is vibes and a discount code. The phrase "drugs are working" implies a clear cause-and-effect between semaglutide and weight loss, but no before-and-after data, lab results, or clinical context is offered. The caption's claim that this is "not an ad" sits awkwardly next to a bio link offering a discount, which is a structure that the FTC has increasingly scrutinized as undisclosed sponsorship. Viewers are essentially being asked to trust a six-word loop as a health recommendation.

Does the science back up the general claim that semaglutide works?

On the core premise, yes, the science is real and substantial. Semaglutide does produce meaningful weight loss in clinical populations, and dismissing that would be dishonest.

The landmark STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that weekly subcutaneous semaglutide 2.4 mg produced an average body weight reduction of 14.9% over 68 weeks in adults with obesity or overweight with a weight-related condition. That's not a trivial number. The SELECT trial (Lincoff et al., 2023, NEJM) further showed cardiovascular risk reduction in people with obesity and established cardiovascular disease, which added a meaningful clinical dimension beyond cosmetic weight loss. GLP-1 receptor agonists work primarily by slowing gastric emptying and acting on hypothalamic satiety signals, which reduces caloric intake. The mechanism is legitimate. The benefit is real for eligible patients under medical supervision.

What did they get wrong, or right?

Credit where it's due: semaglutide is not snake oil. If this creator did lose weight on a properly prescribed, medically supervised semaglutide regimen, that experience is plausible and consistent with clinical data. The drug works for many people.

But here's where the video becomes a problem. First, "drugs are working" strips all nuance from a medication that carries a real side effect profile, including nausea, vomiting, pancreatitis risk, and a boxed warning about thyroid C-cell tumors seen in rodent models. Second, presenting a discount-linked recommendation as "not an ad" is a credibility problem, not a minor footnote. Third, the complete absence of any mention of medical oversight normalizes self-directed use of a prescription-only medication. Compounded semaglutide, which is what many discount-code platforms supply, is not equivalent to FDA-approved Wegovy or Ozempic. The FDA has explicitly warned that compounded versions vary in purity, concentration, and formulation. Viewers who follow a discount link have no way of knowing what they're actually ordering.

What should you actually know?

Semaglutide is a prescription medication, full stop. No TikTok video, regardless of view count, changes that. The 2.4 mg weekly dose used in STEP trials is FDA-approved for chronic weight management under the brand name Wegovy, specifically for adults with a BMI of 30 or above, or 27 or above with at least one weight-related comorbidity.

If you're considering GLP-1 therapy, the starting point is a clinician who can review your full medical history, not a bio link. People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use semaglutide. Drug interactions, contraindications, and titration schedules matter. The STEP trials also showed that most participants regained significant weight after stopping the drug (Wilding et al., 2022, Diabetes, Obesity and Metabolism), which means this is rarely a short-term intervention. That context is entirely absent from a six-word video loop.

• Semaglutide produces real, clinically significant weight loss in appropriately selected patients.
• It is a prescription medication with a real side effect profile and contraindications.
• Compounded semaglutide is not the same as FDA-approved Wegovy or Ozempic.
• A discount code in a bio does not constitute medical advice or oversight.
• Weight often returns after discontinuation, which is critical context for anyone starting treatment.